Edit |   |
---|---|
Antigenic Specificity | IL1A, Human (Bermekimab biosimilar) |
Clone | Bermekimab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL1A Recombinant Antibody. Bermekimab[1] (MABp1, trade name Xilonix) is a human monoclonal antibody of IgG1k isotype targeting Interleukin 1 alpha (IL1A). As of March 2017, bermekimab is in phase III clinical trials as an immunotherapy for colorectal cancer and as of September 2018 in phase II clinical trials for the treatment of atopic dermatitis. |
Immunogen | n/a |
Other Names | Anti-IL1A Recombinant Antibody, Research Grade Bermekimab, Anti-Human IL1A Recombinant Antibody, MABp1, Xilonix, Antibody Drug Analogues, Monoclonal Antibody, YR1369, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1401965-15-8 |
Catalog # | YR1369 |
Price | please inquire |
Order / More Info | IL1A, Human (Bermekimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |